Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
2 Pathogenesis of IBD Since its emergence in the western world over a century ago, the epidemiology of IBD has undergone a significant shift ( 2.1 Dysbiosis of intestinal flora A reduction in the abundance and diversity of specific bacterial genera in the gut microbiota, as well as alterations in microbiota-derived metabolites, has been identified as a potential key factor in the pathogenesis of IBD ( Roseburia and Phascolarctobacterium , were markedly decreased in UC and CD patients in contrast to healthy people ( Roseburia is known for its role in promoting the generation of gut anti-inflammatory regulatory T cells ( Phascolarctobacterium metabolizes succinate to generate propionate when in co-culture with Paraprevotella ( Phascolarctobacterium populations in IBD patients may impair the production of propionate, thus diminishing the anti-inflammatory effects of SCFAs and contributing to the exacerbation of IBD symptoms
Concomitant use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with heart failure
H Ansar, Z Mazloom, F Kazemi, M Hejazi
View Dr Rimas Geigas profile References US Food and Drug Administration
de VosWMTilgHVan HulMCaniPD
12 g Volume: see packaging
/product/05/3175523/2.jpg?6751)
US$ 28.96
US$ 20.58
US$ 28.87
US$ 20.26
US$ 28.33
US$ 23.98
